Terms: = Ovarian cancer AND SDC4, ENSG00000124145, 6385, P31431, SYND4, MGC22217
8 results:
1. Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer.
Carvalho RF; do Canto LM; Abildgaard C; Aagaard MM; Tronhjem MS; Waldstrøm M; Jensen LH; Steffensen KD; Rogatto SR
Cell Commun Signal; 2022 Nov; 20(1):176. PubMed ID: 36352420
[TBL] [Abstract] [Full Text] [Related]
2. Computational modeling of malignant ascites reveals CCL5-sdc4 interaction in the immune microenvironment of ovarian cancer.
Kim S; Han Y; Kim SI; Lee J; Jo H; Wang W; Cho U; Park WY; Rando TA; Dhanasekaran DN; Song YS
Mol Carcinog; 2021 May; 60(5):297-312. PubMed ID: 33721368
[TBL] [Abstract] [Full Text] [Related]
3. Syndecan-1 modulates the invasive potential of endometrioma via TGF-β signalling in a subgroup of women with endometriosis.
Ponandai-Srinivasan S; Saare M; Boggavarapu NR; Frisendahl C; Ehrström S; Riethmüller C; García-Uribe PA; Rettkowski J; Iyengar A; Salumets A; Lalitkumar PGL; Götte M; Gemzell-Danielsson K
Hum Reprod; 2020 Oct; 35(10):2280-2293. PubMed ID: 32897364
[TBL] [Abstract] [Full Text] [Related]
4. Population-based targeted sequencing of 54 candidate genes identifies
Song H; Dicks EM; Tyrer J; Intermaggio M; Chenevix-Trench G; Bowtell DD; Traficante N; Group A; Brenton J; Goranova T; Hosking K; Piskorz A; van Oudenhove E; Doherty J; Harris HR; Rossing MA; Duerst M; Dork T; Bogdanova NV; Modugno F; Moysich K; Odunsi K; Ness R; Karlan BY; Lester J; Jensen A; Krüger Kjaer S; Høgdall E; Campbell IG; Lázaro C; Pujara MA; Cunningham J; Vierkant R; Winham SJ; Hildebrandt M; Huff C; Li D; Wu X; Yu Y; Permuth JB; Levine DA; Schildkraut JM; Riggan MJ; Berchuck A; Webb PM; Group OS; Cybulski C; Gronwald J; Jakubowska A; Lubinski J; Alsop J; Harrington P; Chan I; Menon U; Pearce CL; Wu AH; de Fazio A; Kennedy CJ; Goode E; Ramus S; Gayther S; Pharoah P
J Med Genet; 2021 May; 58(5):305-313. PubMed ID: 32546565
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical characteristics and risk factors of pelvic mass in women after hysterectomy for benign disease].
Xu XX; Li T; Dai Y; Zhang JJ; Lang JH; Leng JH
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):526-532. PubMed ID: 28851169
[No Abstract] [Full Text] [Related]
6. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
7. Functional proteomics, human genetics and cancer biology of GIPC family members.
Katoh M
Exp Mol Med; 2013 Jun; 45(6):e26. PubMed ID: 23743496
[TBL] [Abstract] [Full Text] [Related]
8. In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer.
Israeli O; Goldring-Aviram A; Rienstein S; Ben-Baruch G; Korach J; Goldman B; Friedman E
Cancer Genet Cytogenet; 2005 Jul; 160(1):35-42. PubMed ID: 15949568
[TBL] [Abstract] [Full Text] [Related]
